Iron-chelating therapy with the new oral agent ICL670 (Exjade®)

• 30 June 2005
• journal article
• review article
• Published by Elsevier in Best Practice & Research Clinical Haematology
• Vol. 18  (2) , 289-298
• https://doi.org/10.1016/j.beha.2004.09.002

Abstract

Keywords

• CHELATING
• EFFICACY
• ICL670
• IRON CHELATION
• SAFETY
• TOLERABILITY
• DEFEROXAMINE
• ORAL
• OVERLOADED